Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 4
1972 1
1973 1
1975 2
1976 6
1977 4
1978 6
1980 8
1981 6
1982 6
1983 6
1984 1
1985 3
1986 2
1987 2
2007 1
2008 1
2010 1
2011 1
2012 3
2014 3
2015 2
2016 5
2017 1
2018 4
2019 4
2020 10
2021 6
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Phytocannabinoids in the Pharmacotherapy of Psoriasis.
Wroński A, Jarocka-Karpowicz I, Stasiewicz A, Skrzydlewska E. Wroński A, et al. Molecules. 2023 Jan 25;28(3):1192. doi: 10.3390/molecules28031192. Molecules. 2023. PMID: 36770858 Free PMC article. Review.
Proteomic plasma profile of psoriatic patients.
Gęgotek A, Domingues P, Wroński A, Wójcik P, Skrzydlewska E. Gęgotek A, et al. Among authors: wronski a. J Pharm Biomed Anal. 2018 Jun 5;155:185-193. doi: 10.1016/j.jpba.2018.03.068. Epub 2018 Apr 4. J Pharm Biomed Anal. 2018. PMID: 29635173
Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B; kConFab; Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P. Brewster BL, et al. Among authors: wronski a. Hum Mutat. 2012 Dec;33(12):1665-75. doi: 10.1002/humu.22159. Epub 2012 Aug 2. Hum Mutat. 2012. PMID: 22753153
Cell Fate Decisions During Breast Cancer Development.
Gross K, Wronski A, Skibinski A, Phillips S, Kuperwasser C. Gross K, et al. Among authors: wronski a. J Dev Biol. 2016 Mar 1;4(1):4. doi: 10.3390/jdb4010004. Epub 2016 Jan 22. J Dev Biol. 2016. PMID: 27110512 Free PMC article.
101 results